We invested early in scaling our in-house capabilities and have established the manufacturing and production together with our digital factory partner Siemens to develop a process for the fully-automated, on-demand production of mRNA therapies because in order to successfully bring individualized immunotherapies to patients, it is critical to control the manufacturing and supply processes.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
24
Aug 2026
According to numbers calculated from the CDC, approximately 80,000 people died last year from a drug overdose, which represents about 21 deaths per 100,000 residents in the U.S. alone. Overdose deaths are preventable, and in most of the cases we see, they are completely accidental.
24
Aug 2026
A new multi-institute study led by researchers at Dartmouth Health and Geisel School of Medicine at Dartmouth suggests that alpha-gal syndrome, the tick-borne disease that can result in a chronic allergy to meat and animal byproducts, also may complicate certain patients' ability to safely receive a blood plasma or platelet transfusion.
24
Aug 2026
When one person helps, or refuses to help, another in public, this may change not only the provider's reputation but also the recipient's.
24
Aug 2026
Across 11 annual U.S. surveys involving about 183,000 adults, higher social media use was consistently associated with self-reported depression, with social media ranking among the strongest predictors in machine-learning models. SHAP analyses suggested that social media use became a stronger positive signal for depression at around 150 minutes per day, although the authors stress that this is not an established clinical threshold and requires longitudinal and experimental testing.